XTL Biopharmaceuticals Ltd ADR Cash Flow Quality Index
XTL Biopharmaceuticals Ltd ADR cash flow quality index. XTL Biopharmaceuticals Ltd ADR (XTLB) has a Cash Flow Quality Index of 0.04x as of December 2021. Operating cash flow of $79.00K is below net income of $2.10 Million, suggesting accrual-heavy earnings not yet converted to cash. See how financially flexible is XTL Biopharmaceuticals Ltd ADR to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of XTL Biopharmaceuticals Ltd ADR (2009–2021)
Cash flow quality index of XTL Biopharmaceuticals Ltd ADR from 2009 to 2021. Historical Cash Flow Quality Index for XTL Biopharmaceuticals Ltd ADR across 3 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore debt repayment capacity of XTL Biopharmaceuticals Ltd ADR to assess how comfortably operating cash covers total debt obligations.
XTL Biopharmaceuticals Ltd ADR Cash Flow Quality Index by Year (2009–2021)
XTL Biopharmaceuticals Ltd ADR cash flow quality index by year from 2009 to 2021. Year-by-year earnings quality comparison for XTL Biopharmaceuticals Ltd ADR. For the full cash flow conversion analysis, see how efficiently does XTL Biopharmaceuticals Ltd ADR generate cash.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2021 | -2.41x | $-1.05 Million | $435.00K | ▼ -782.4% |
| 2018 | -0.27x | $-816.00K | $2.99 Million | ▲ +71.6% |
| 2009 | -0.96x | $-2.49 Million | $2.59 Million | — |